Skip to main content

Table 2 Day 90 Outcomes of the Patients with AIS and ICH with Day 4 mRS 3-5 who were discharged to IRF on day 2-14

From: Essential information for neurorecovery clinical trial design: trajectory of global disability in first 90 days post-stroke in patients discharged to acute rehabilitation facilities

 

AIS

ICH

P value

mRS Change Day 4 to Day 90

 All patients, mean (SD)

-1.34 (1.37)

-1.60 (1.18)

0.08

 Patients with mRS 3 on Day 4, mean (SD)

-1.19 (1.24)

-1.10 (0.88)

0.83

 Patients with mRS 4 on Day 4, mean (SD)

-1.32 (1.44)

-1.65 (1.08)

0.16

 Patients with mRS 5 on Day 4, mean (SD)

-1.43 (1.33)

-1.67 (1.31)

0.34

Day 90 mRS Outcomes

 Nondisabled, mRS 0–1, N (%)

42 (20.3)

12 (11.3)

0.09

 Independent, mRS 0–2, N (%)

102 (45.1)

56 (52.8)

0.19

 Ambulatory, mRS 0–3, N (%)

151 (66.8)

80 (75.5)

0.11

mRS score

 Mean (SD)

2.8 (1.5)

2.8 (1.3)

 

 Median (IQR)

3 (2–4)

2 (2–3)

0.53

Mortality, (mRS 6) N (%)

11 (4.8)

3 (2.8)

0.39

Barthel Indexa

  

0.21

   Day 90 Mean (SD)

75.9 (28.9)

80.5 (26.8)

   Median (IQR)

90 (60, 100)

90 (75, 100)

Glasgow Outcome Scaleb

  

0.08

   Day 90 Mean (SD)

2.32 (1.02)

2.12 (0.90)

   Median (IQR)

2 (1,5)

2 (1,5)

  1. aBarthel Index day 90 scores were missing in 13/226 (5.8%) AIS patients and 9/110 (8.2%) ICH patients
  2. bGlasgow Outcome Scale scores were missing in 1/226 (0.4%) and 5/110 (4.5%)